The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
Zhejiang Huahai Pharmaceutical tablet application receives FDA clearance
Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SH) announced Friday that its abbreviated new drug application (ANDA) for 50mg doxycycline hydrochloride sustained-release tablets had gotten the approval of the U.S. Food and Drug Administration (FDA ).
February22,2019
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
